Download PDF
March 30, 2021

SOT FDA Colloquia Series Will Include Webcast on the Toxicology of Nanoparticles

Lynn L. Bergeson Carla N. Hutton

The Society of Toxicology (SOT) in conjunction with the U.S. Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) have partnered to provide a colloquia series on Emerging Toxicological Science:  Challenges in Food and Ingredient Safety.  The colloquia will present scientific information that is high-quality, cutting-edge, future-oriented toxicological science and is intended to provide a well-grounded foundation to inform the work of FDA employees.  On April 8, 2021, there will be a live webcast on the toxicology of nanoparticles.  Richard Canady, Ph.D., and Kapal Dewan, MS, CLSp(CG), are Colloquium Co-Chairs.  The agenda includes:

  • Welcome, George Daston, SOT President, Procter & Gamble Company;
  • Overview and Speaker Introductions, Richard Canady, Ph.D., NeutralScience LC3;
  • Lessons Learned from Nanomaterial Characterization: Critical Quality Attributes that Influence Biological Properties, Anil Patri, Ph.D., National Center for Toxicological Research (NCTR);
  • Standard Dose Measurement for Nanomaterials: What to Include in Exposure and Toxicity so That We Can Bound Dose Estimates for Safety?, Christie Sayes, Ph.D., Baylor University;
  • Dosing-Related Challenges in Toxicity Studies and Risk Assessment of Titanium Dioxide in Food, Walter Brand, Ph.D., National Institute for Public Health and the Environment (RIVM) in The Netherlands;
  • Practical Application to Regulatory Toxicology: Issues Faced in Consideration of Developing Health Guideline Values, Lynne Haber, Ph.D., University of Cincinnati Risk Science Center; and
  • Roundtable discussion moderated by Richard Canady, Ph.D., and including all speakers, as well as Timothy Duncan, Ph.D., FDA, and Agnes Oomen, Ph.D., RIVM.

The webcast is open to the public at no charge.  Registration will require creating an online account.  SOT notes that these sessions are not a public forum to discuss toxicology regulatory issues.